Recommendations for ADT have become much more nuanced in the past few years, especially with advanced genetic screening, so anything you've read about overtreatment that is based on research conducted before the pandemic might not be relevant any more. They no longer automatically slap people on ADT just because of a high PSA reading or a dubious biopsy, and they support "ADT holidays" for people with low-grade, non-metastatic cancer to help the body recover from the side-effects.

In any case, it's keeping me alive with my stage-4 cancer, so for my case "Go, ADT!"

And so the debate continues!!
https://www.urotoday.com/conference-highlights/aua-2023/aua-2023-prostate-cancer/144054-aua-2023-debate-renaming-gleason-6-prostate-cancer.html